Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2014, Article ID 238780, 9 pages
http://dx.doi.org/10.1155/2014/238780
Research Article

Biochemical and Neurotransmitters Changes Associated with Tramadol in Streptozotocin-Induced Diabetes in Rats

1Drug Bioavailability Laboratory, College of Pharmacy, King Saud University, P.O. Box 2457, Riyadh 11451, Saudi Arabia
2National Organization for Drug Control and Research, P.O. Box 29 Cairo, Egypt
3Pharmacology and Toxicology Department, Faculty of Pharmacy (Girls), Al Azhar University, Cairo, Egypt
4Pharmacognosy Department, College of Pharmacy, King Saud University, P.O. Box 2457, Riyadh 11451, Saudi Arabia

Received 2 February 2014; Accepted 23 March 2014; Published 26 May 2014

Academic Editor: George Perry

Copyright © 2014 Essam Ezzeldin et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J.-M. Ekoe, “Recent trends in prevalence and incidence of diabetes mellitus syndrome in the world,” Diabetes Research and Clinical Practice, vol. 1, no. 5, pp. 249–264, 1985. View at Google Scholar · View at Scopus
  2. M. N. Elbagir, M. A. Eltom, E. M. Elmahadi, I. M. Kadam, and C. Berne, “A high prevalence of diabetes mellitus and impaired glucose tolerance in the Danagla community in northern Sudan,” Diabetic Medicine, vol. 15, pp. 164–169, 1998. View at Google Scholar
  3. A. S. Shera, G. Rafique, I. A. Khawaja, S. Baqai, and H. King, “Pakistan National Diabetes Survey: prevalence of glucose intolerance and associated factors in Baluchistan province,” Diabetes Research and Clinical Practice, vol. 44, no. 1, pp. 49–58, 1999. View at Publisher · View at Google Scholar · View at Scopus
  4. H. King, R. E. Aubert, and W. H. Herman, “Global burden of diabetes, 1995–2025: prevalence, numerical estimates, and projections,” Diabetes Care, vol. 21, no. 9, pp. 1414–1431, 1998. View at Google Scholar · View at Scopus
  5. H. H. Hennies, E. Friderichs, and J. Schneider, “Receptor binding, analgesic and antitussive potency of tramadol and other selected opioids,” Arzneimittel-Forschung, vol. 38, no. 7, pp. 877–880, 1988. View at Google Scholar · View at Scopus
  6. R. B. Raffa, E. Friderichs, W. Reimann, R. P. Shank, E. E. Codd, and J. L. Vaught, “Opioid and nonopioid components independently contribute to the mechanism of action of tramadol, an “atypical” opioid analgesic,” Journal of Pharmacology and Experimental Therapeutics, vol. 260, no. 1, pp. 275–285, 1992. View at Google Scholar · View at Scopus
  7. K. McClellan and L. J. Scott, “Tramadol/Paracetamol,” Drugs, vol. 63, no. 11, pp. 1079–1086, 2003. View at Publisher · View at Google Scholar · View at Scopus
  8. A. Faron-Górecka, M. Kuśmider, S. Y. Inan, J. Siwanowicz, T. Piwowarczyk, and M. Dziedzicka-Wasylewska, “Long-term exposure of rats to tramadol alters brain dopamine and α1-adrenoceptor function that may be related to antidepressant potency,” European Journal of Pharmacology, vol. 501, no. 1–3, pp. 103–110, 2004. View at Publisher · View at Google Scholar · View at Scopus
  9. E. E. Codd, R. P. Shank, J. J. Schupsky, and R. B. Raffa, “Serotonin and norepinephrine uptake inhibiting activity of centrally acting analgesics: Structural determinants and role in antinociception,” Journal of Pharmacology and Experimental Therapeutics, vol. 274, no. 3, pp. 1263–1270, 1995. View at Google Scholar · View at Scopus
  10. M. S. Chong and J. Hester, “Diabetic painful neuropathy: current and future treatment options,” Drugs, vol. 67, no. 4, pp. 569–585, 2007. View at Publisher · View at Google Scholar · View at Scopus
  11. R. Freeman, P. Raskin, D. J. Hewitt et al., “Randomized study of tramadol/acetaminophen versus placebo in painful diabetic peripheral neuropathy,” Current Medical Research and Opinion, vol. 23, no. 1, pp. 147–161, 2007. View at Publisher · View at Google Scholar · View at Scopus
  12. J. T. Cheng, I. M. Liu, T. C. Chi, T. F. Tzeng, F. H. Lu, and C. J. Chang, “Plasma glucose-lowering effect of tramadol in streptozotocin-induced diabetic rats,” Diabetes, vol. 50, no. 12, pp. 2815–2821, 2001. View at Google Scholar · View at Scopus
  13. H. Lavasani, B. Sheikholeslami, Y. H. Ardakani, M. Abdollahi, L. Hakemi, and M. R. Rouini, “Study of the pharmacokinetic changes of Tramadol in diabetic rats,” Daru, vol. 21, no. 1, article 17, 2013. View at Publisher · View at Google Scholar
  14. S. Atici, I. Cinel, L. Cinel, N. Doruk, G. Eskandari, and U. Oral, “Liver and kidney toxicity in chronic use of opioids: an experimental long term treatment model,” Journal of Biosciences, vol. 30, no. 2, pp. 245–252, 2005. View at Google Scholar · View at Scopus
  15. P. Bloms-Funke, E. Dremencov, T. I. F. H. Cremers, and T. M. Tzschentke, “Tramadol increases extracellular levels of serotonin and noradrenaline as measured by in vivo microdialysis in the ventral hippocampus of freely-moving rats,” Neuroscience Letters, vol. 490, no. 3, pp. 191–195, 2011. View at Publisher · View at Google Scholar · View at Scopus
  16. N. Kato, Y. Hou, Z. Lu et al., “Kallidinogenase normalizes retinal vasopermeability in streptozotocin-induced diabetic rats: Potential roles of vascular endothelial growth factor and nitric oxide,” European Journal of Pharmacology, vol. 606, no. 1–3, pp. 187–190, 2009. View at Publisher · View at Google Scholar · View at Scopus
  17. M. Kanter, “Protective effects of thymoquinone on streptozotocin-induced diabetic nephropathy,” Journal of Molecular Histology, vol. 40, no. 2, pp. 107–115, 2009. View at Publisher · View at Google Scholar · View at Scopus
  18. G. Munro, “Pharmacological assessment of the rat formalin test utilizing the clinically used analgesic drugs gabapentin, lamotrigine, morphine, duloxetine, tramadol and ibuprofen: influence of low and high formalin concentrations,” European Journal of Pharmacology, vol. 605, no. 1–3, pp. 95–102, 2009. View at Publisher · View at Google Scholar · View at Scopus
  19. A. E. Ciarlone, “Further modification of a fluorometric method for analyzing brain amines,” Microchemical Journal, vol. 23, no. 1, pp. 9–12, 1978. View at Google Scholar · View at Scopus
  20. S. Reitman and S. Frankel, “A colorimetric method for the determination of serum glutamic oxalacetic and glutamic pyruvic transaminases,” American journal of clinical pathology, vol. 28, no. 1, pp. 56–63, 1957. View at Google Scholar · View at Scopus
  21. J. D. Bancroft and A. Stevens, Theory and Practice of Histological Techniques, Churchill Levingstone, New York, NY, USA, 1996.
  22. Z. Lackovic, M. Salkovic, Z. Kuci, and M. Relja, “Effect of long-lasting diabetes mellitus on rat and human brain monoamines,” Journal of Neurochemistry, vol. 54, no. 1, pp. 143–147, 1990. View at Publisher · View at Google Scholar · View at Scopus
  23. Y. Shimomura, H. Shimizu, M. Takahashi, Y. Uehara, I. Kobayashi, and S. Kobayashi, “Ambulatory activity and dopamine turnover in streptozotocin-induced diabetic rats,” Experimental and Clinical Endocrinology, vol. 95, no. 3, pp. 385–388, 1990. View at Google Scholar · View at Scopus
  24. R. Ramakrishnan, R. Sheeladevi, N. Suthanthirarajan, and A. Namasivayam, “An acute hyperglycemia or acidosis-induced changes of indolamines level correlates with PKC-α expression in rat brain,” Brain Research Bulletin, vol. 67, no. 1-2, pp. 46–52, 2005. View at Publisher · View at Google Scholar · View at Scopus
  25. R. Ramakrishnan and A. Namasivayam, “Norepinephrine and epinephrine levels in the brain of alloxan diabetic rats,” Neuroscience Letters, vol. 186, no. 2-3, pp. 200–202, 1995. View at Publisher · View at Google Scholar · View at Scopus
  26. N. M. Hamdy and R. A. Taha, “Effects of nigella sativa oil and thymoquinone on oxidative stress and neuropathy in streptozotocin-induced diabetic rats,” Pharmacology, vol. 84, no. 3, pp. 127–134, 2009. View at Publisher · View at Google Scholar · View at Scopus
  27. G. Manjarrez, J. L. Contreras, G. Chagoya, and J. Hernández-R, “Free tryptophan as an indicator of brain serotonin synthesis in infants,” Pediatric Neurology, vol. 18, no. 1, pp. 57–62, 1998. View at Publisher · View at Google Scholar · View at Scopus
  28. D. M. Halfpenny, L. F. Callado, S. E. Hopwood, T. A. Bamigbade, R. M. Langford, and J. A. Stamford, “Effects of tramadol stereoisomers on norepinephrine efflux and uptake in the rat locus coeruleus measured by real time voltammetry,” British Journal of Anaesthesia, vol. 83, no. 6, pp. 909–915, 1999. View at Google Scholar · View at Scopus
  29. M. C. Frink, H. H. Hennies, W. Englberger, M. Haurand, and B. Wilffert, “Influence of tramadol on neurotransmitter systems of the rat brain,” Arzneimittel-Forschung, vol. 46, no. 11, pp. 1029–1036, 1996. View at Google Scholar · View at Scopus
  30. I. Yalcin, F. Aksu, S. Bodard, S. Chalon, and C. Belzung, “Antidepressant-like effect of tramadol in the unpredictable chronic mild stress procedure: Possible involvement of the noradrenergic system,” Behavioural Pharmacology, vol. 18, no. 7, pp. 623–631, 2007. View at Publisher · View at Google Scholar · View at Scopus
  31. T. A. Bamigbade, C. Davidson, R. M. Langford, and J. A. Stamford, “Actions of tramadol, its enantiomers and principal metabolite, O-desmethyltramadol, on serotonin (5-HT) efflux and uptake in the rat dorsal raphe nucleus,” British Journal of Anaesthesia, vol. 79, no. 3, pp. 352–356, 1997. View at Google Scholar · View at Scopus
  32. J. P. Zacny, “Profiling the subjective, psychomotor, and physiological effects of tramadol in recreational drug users,” Drug and Alcohol Dependence, vol. 80, no. 2, pp. 273–278, 2005. View at Publisher · View at Google Scholar · View at Scopus
  33. S. Asgary, P. Rahimi, and P. Mahzouni H Madani, “Antidiabetic effect of hydroalcoholic extract of Carthamus tinctorius L. in alloxan-induced diabetic rats,” Journal of Research in Medical Sciences, vol. 17, pp. 386–392, 2011. View at Google Scholar
  34. V. Bhole, J. W. J. Choi, S. Woo Kim, M. de Vera, and H. Choi, “Serum uric acid levels and the risk of type 2 diabetes: a prospective study,” American Journal of Medicine, vol. 123, no. 10, pp. 957–961, 2010. View at Publisher · View at Google Scholar · View at Scopus
  35. N. H. Al-Rawi, “Oxidative stress, antioxidant status and lipid profile in the saliva of type 2 diabetics,” Diabetes and Vascular Disease Research, vol. 8, no. 1, pp. 22–28, 2011. View at Publisher · View at Google Scholar · View at Scopus
  36. R. Shafiee-Nick, A. Ghorbani, F. Vafaee bagheri, and H. Rakhshandeh, “Chronic administration of a combination of six herbs inhibits the progression of hyperglycemia and decreases serum lipids and aspartate amino transferase activity in diabetic rats,” Advances in Pharmacological Sciences, pp. 789–796, 2012. View at Google Scholar
  37. C. Wang, Y. Pan, Q. Y. Zhang, F. M. Wang, and L. D. Kong, “Quercetin and allopurinol ameliorate kidney injury in STZ-treated rats with regulation of renal NLRP3 inflammasome activation and lipid accumulation,” PLoS ONE, vol. 7, Article ID e38285, 2012. View at Google Scholar